PULMONARY INFARCTION

This adverse event was reported 2367 times

PULMONARY INFARCTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Sclerosing Agent [EPC] 1 0.0022
1 Estrogen [EPC] 349 0.0019
2 Nucleoside Analog Antifungal [EPC] 2 0.0014
3 Progestin [EPC] 358 0.0012
4 beta Lactamase Inhibitor [EPC] 5 0.0011
5 Androgen [EPC] 24 0.0009
6 Vitamin D2 Analog [EPC] 6 0.0008
7 Dihydrofolate Reductase Inhibitor Antimalarial [EPC] 1 0.0008
8 Sulfonamide Antibacterial [EPC] 3 0.0008
9 Monobactam Antibacterial [EPC] 2 0.0007
See all drug classes enriched for association with PULMONARY INFARCTION